AI發明的專利適格性與進步性之研究

The Study of the Patent Eligibility and Inventive Step of Inventions of Artificial Intelligence

周伯翰(Bo-Han Jou)

人工智慧 ； 專利 ； 專利適格性 ； 進步性 ； 非顯著性 ； artificial intelligence ； patents ； patent eligibility ； inventive step ； nonobviousness

高大法學論叢

17卷2期（2022 / 03 / 01）

95 - 99+101

繁體中文

因AI可用於眾多科技領域，如使用AI的心臟功能監測設備、協助醫師診斷癌症的AI設備、使用AI控制交通工具、使用AI為核心的理財機器、使用AI設計工業產品、結合AI與機器視覺用於檢測異常產品、將AI分類演算法的數位影像技術用於語言辨識與數位遊戲及專家執業的數位系統。醫界已廣泛運用卷積神經網路作為「深度學習」網路，並將其用於疾病的影像判讀與分類，如用於皮膚科、眼科、病理學、侵入性放射學等，故AI相關發明越來越受各界重視。由於將AI用於特定領域以解決特定問題係出於人類構思，即使AI能自行蒐集資料、選用參數、深度學習、生成結果，其主要仍依人類設計的原則運作。雖然南非專利局認定AI系統DABUS係發明人，且澳洲聯邦法院裁定AI系統DABUS為專利發明人，惟專利制度發達的主要國家與地區皆未承認AI為專利發明人，更遑論授予AI專利權；台灣智慧財產及商業法院亦駁回以AI系統DABUS為專利發明人之主張。隨「邊緣運算」技術出現，AI可降低資料取得成本並增強資料隱私性能，故可使AI更能普遍用於物聯網，而更融入日常生活，所以專利制度發達的主要國家與地區越來越重視AI專利相關法制。因此，本文將研究美國、歐洲與台灣有關AI發明的「專利適格性」與「進步性」之法制，並歸納其法律原則，俾法院與智慧局在審理AI專利爭議案件時能有較清晰且有系統的參考依據。

Because AI can be applied to many fields of technology, for example, heart function monitoring equipment using AI, AI equipment to assist physicians in diagnosing cancer, using AI to control means of transportation, the financial management machine using AI as the core, using AI to design industrial products, combining AI and machine vision to detect abnormal products, or digital imaging technologies using AI classification algorithms applied to language recognition, digital games, and digital systems related to the practice of professionals. The medical field has widely used convolutional neural networks as ＂deep learning＂ networks, and has applied the AI systems with ＂deep learning＂ networks to the image interpretation and classification regarding diseases, for instance, used in dermatology, ophthalmology, pathology, interventional radiology, etc.; therefore, AI-related inventions have received increasing attention from all social circles. Because the application of AI to specific areas to solve specific problems is derived from human ideas, even if AI can collect data, select parameters, deeply learn, and generate results by itself, it still mainly operates according to the principles designed by human. Although the South African Patent Office identifies the AI system DABUS as the inventor, and the Australian Federal Court rules that the AI system DABUS is the patent inventor, but major countries and regions with developed patent systems have not recognized AI as the patent inventor, let alone granting AI patent rights; Taiwan's Intellectual Property and Commercial Court also rejects the claim that the AI system DABUS is the patent inventor. With the emergence of ＂edge computing＂ technology, AI can reduce the cost of data acquisition and enhance the performance of data privacy, so it can make AI more universally applied to the Internet of Things, and more integrated into daily lives; therefore, the AI patent-related legal systems in major countries and regions with developed patent systems is becoming more and more important. Consequently, this article will study the legal systems of the ＂patent eligibility＂ and ＂inventive step＂ of AI inventions in the United States, Europe, and Taiwan, and summarize the legal principles thereof, so that courts and the Intellectual Property Office can have clearer and more systematic reference bases when hearing AI patent dispute cases.

1. 林昕璇(2021)。AI 自主性武器系統在國際法上適用之研析。軍法專刊，67(4)，20-44。
   連結：
2. 龍建宇,莊弘鈺(2019)。人工智慧於司法實務之可能運用與挑戰。國立中正大學法學集刊，62，43-108。
   連結：
3. European software patents FAQ, at https://www.bardehle.com/europeansoftwarepatents/faq/what-is-the-comvik-approach/ (last visited 08/20/2021).
4. 2019 Revised Patent Subject Matter Eligibility Guidance, available at https://www.federalregister.gov/documents/2019/01/07/2018-28282/2019-revised-patent-subject-matter-eligibility-guidance (last visited 08/20/2021).
5. 2106 Patent Subject Matter Eligibility, at https://www.uspto.gov/web/offices/pac/mpep/s2106.html (last visited 08/20/2021).
6. The United States Patent and Trademark Office, Manual of Patent Examining Procedure (MPEP), Chapter 700, Ninth Edition, at https://www.uspto.gov/web/offices/pac/mpep/mpep-0700.pdf (last visited 08/20/2021).
7. Manual of Patent Examining Procedure (MPEP) Ninth Edition, Revision 10.2019, Last Revised June 2020 (2020), available at https://www.uspto.gov/web/offices/pac/mpep/index.html (last visited 08/20/2021).
8. The European Software Patents Knowledge Base, at https://www.bardehle.com/europeansoftwarepatents/knowledge-base/only-technical-features-can-establish-an-inventive-step/ (last visited 08/20/2021).
9. The United States Patent and Trademark Office, Manual of Patent Examining Procedure (MPEP), 2141, Ninth Edition, at https://www.uspto.gov/web/offices/pac/mpep/mpep-2100.pdf (last visited 08/20/2021).
10. (2016).The European Patent Convention.
11. Examination Guidelines for Determining Obviousness Under 35 U.S.C. 103, available at https://www.uspto.gov/web/offices/pac/mpep/s2141.html (last visited 08/20/2021).
12. Acs, B.,Rantalainen, M.,Hartman, J.(2020).Artificial intelligence as the next step towards precision pathology.Journal of Internal Medicine,288(1),62-81.
13. Curran, John, USPTO Rolls Out First AI Project to Speed Patent Exam Process, at https://www.meritalk.com/articles/uspto-rolls-out-first-ai-project-to-speed-patent-exam-process/ (last visited 08/20/2021).
14. Engle, Eric(2004).An Introduction to Artificial Intelligence and Legal Reasoning: Using Xtalk to Model the Alien Tort Claims Act and Torture Victim Protection Act.St. John's Journal of Law Commentary,11(2),1-37.
15. European Commission, Commission Staff Working Document Accompanying the document communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society, COM (2018) 233 final, 25.4.2018, available at https://eur-lex.europa.eu/legal-content/IT/ALL/?uri=CELEX:52018SC0126 (last visited 08/20/2021).
16. Heckeler, Patrick, Software patent applications: How the EPO examines innovative software, at https://www.bardehle.com/europeansoftwarepatents/software-patent-epo/ (last visited 08/20/2021).
17. Hogarty, Daniel T.,Su, John C.,Phan, Kevin(2020).Artificial intelligence in dermatology-where we are and the way to the future: a review.American Journal of Clinical Dermatology,21(1),41-47.
18. Iancu, Andrei, Remarks by Director Iancu at the Intellectual Property Owners Association 46th Annual Meeting, at https://www.uspto.gov/about-us/news-updates/remarks-director-iancu-intellectual-property-owners-46th-annual-meeting (last visited 08/20/2021).
19. Iezzi, Robert,Goldberg, S.N.,Merlino, B.,Posa, A.,Valentini, V.,Manfredi, R.(2019).Artificial Intelligence in Interventional Radiology: A Literature Review and Future Perspectives.Journal of Oncology Practice,6153041.
20. Jakhar, D.,Kaur, I.(2020).Artificial intelligence, machine learning and deep learning: definitions and differences.Clinical and Experimental Dermatology,45(1),131-132.
21. Kapoor, R.,Walters, Stephen P.,Al-Aswad, Lama A.(2019).The current state of artificial intelligence in ophthalmology.Survey of Ophthalmology,64(2),233-240.
22. Mcclean, Toby(2021)。選擇邊緣 AI 裝置的重要關鍵。CTIMES，356，63-66。
23. The European Patent Office, Patenting Artificial Intelligence: Conference Summary 4 (2018), available at http://documents.epo.org/projects/babylon/acad.nsf/0/D9F20464038C0753C125829E0031B814/$FILE/summary_conference_artificial_intelligence_en.pdf (last visited 08/20/2021).
24. The European Patent Office, Guidelines for Examination in the European Patent Office, Mar. 2021, at https://documents.epo.org/projects/babylon/eponet.nsf/0/C4B20952A0A7EF6BC125868B002A5C61/$File/epo_guidelines_for_ examination_2021_hyperlinked_showing_modifications_en.pdf (last visited 08/20/2021).
25. WIPO, Index of AI initiatives in IP offices, at https://www.wipo.int/about-ip/en/artificial_intelligence/search.jsp (last visited 08/20/2021)
26. 王岫晨(2021)。提升速度與準確性：結合 AI 管理機器視覺應用領域持續擴增。智動化雜誌，74，28-31。
27. 季平(2021)。放手自駕行不行？感測器融合技術，臨門缺了哪一腳？。CTIMES，357，39-44。
28. 芮嘉瑋(2021)。五大智慧財產局運用 AI 技術導入業務營運的現況與規劃。專利師，46，122-144。
29. 許曉芬(2020)。智慧醫療與專利保護交錯議題初探：用積極的創新讓我們活躍的老去。萬國法律，229，2-10。
30. 經濟部智慧財產局，專利法逐條釋義，https://www.tipo.gov.tw/public/Attachment/410179315298.pdf （ 最後瀏覽日：08/20/2021）。
31. 經濟部智慧財產局，專利審查基準，第 2 篇第 2 章 ，https://topic.tipo.gov.tw/patents-tw/cp-682-870055-ed52d-101.html （最後瀏覽日：08/20/2021）。
32. 經濟部智慧財產局，專利審查基準，第 2 篇第 3 章https://topic.tipo.gov.tw/patents-tw/cp-682-870054-84cb7-101.html （最後瀏覽日：08/20/2021）。
33. 經濟部智慧財產局，專利審查基準，第 2 篇第 12 章 ，https://topic.tipo.gov.tw/patents-tw/cp-682-870083-10557-101.html （最後瀏覽日：08/20/2021）。
34. 劉宗德,戴凡芹(2021)。金融創新與監理革新──以街口投信裁罰案為反思。月旦法學雜誌，316，6-35。
35. 歐敏銓(2021)。鐵道障礙物入侵！AI 如何即時辨識與預警。智動化雜誌，72，10-17。
36. 鄭穎淳,王彥博,侯明志,盧俊良(2021)。人工智慧於醫學影像的應用——北榮內視鏡中心經驗。台北市醫師公會會刊，65(7)，56-58。
37. 籃貫銘,盧傑瑞(2021)。結合物理模擬、AI 與雲端的系統級分析大計：EDA 進化中！。CTIMES，359，34-40。